Novaccess Global
About:
Novaccess Global brings together technological assets, scientific, and executive team to accelerate taking these assets to market.
Website: https://novaccessglobal.com/
Top Investors: Sumner Global
Description:
NovAccess Global is building long-term shareholder value through the intelligent acquisition of assets in clinical-stage research and development, balanced with medical assets in the market. The company brings together technological assets, scientific, and executive team to accelerate taking these assets to market.
Total Funding Amount:
$10.9M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Chesterland, Ohio, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)novaccessglobal.com
Founders:
Dr. Dwain Irvin
Number of Employees:
1-10
Last Funding Date:
2024-01-02
IPO Status:
Public
Industries:
© 2025 bioDAO.ai